Validated complementary quality-of-life instruments
The study applies both the disease-specific HAE-QoL and generic SF-12v2 instruments, permitting complementary characterization of disease burden.
↳ Methods, p.66
Crunching the numbers. Responsibly.
OBJECTIVE: To describe health relaed quality of life in a cohort of stable adult outpatients with hereditary an-gioedema (HAE) with validated tools.
METHODS: An observational, cross-sectional, and descriptive study was performed, carried out in patients with hereditary angioedema, coming from the City of Buenos Aires and its provinces: Corrientes, Chubut, Entre Ríos and Santa Fe. The HAE-QoL and SF-12v2 health questionnaires were applied to assess the related quality of life. with health.
RESULTS: 100 patients were included; median age: 41.5 years (range: 18-77); 65% were female, and 79% had type 1 HAE. Asymptomatic, mild, moderate and severe cases accounted for 6, 29, 38, and 27% of participants, respectively. Seventeen percent of patients were receiving long-term prophylaxis. Icatibant was the most fre-quent treatment for acute episodes. All health domains SF-12v2 scores were lower than expected in general population, excepting "vitality" and "physical functioning". Total and all specific domains HAE-QoL scores were reduced. Differences between women and men and in every age-defined group were demonstrated for sev-eral specific domains.
CONCLUSIONS: Health relaed to quality life was notably reduced in Argentinean patients with HAE, when imple-menting the HAE.QoL, and SF-12v2 questionnaries. The need for multidisciplinary strategies approaching this complex disease is highlighted.
Health relaed to quality life was notably reduced in Argentinean patients with HAE, when implementing the HAE.QoL, and SF-12v2 questionnaries.
validated questionnaires support the direction, while specialist-center sampling and an unspecified population reference constrain generalization
All health domains SF-12v2 scores were lower than expected in general population, excepting “vitality” and “physical functioning”.
the comparative reference population and formal cohort-versus-norm analysis are not specified
Total and all specific domains HAE-QoL scores were reduced.
validated disease-specific scores are consistently reported below the referenced percentiles across Tables 1 and 2
Differences between women and men and in every age-defined group were demonstrated for several specific domains.
small male subgroups prevented formal sex comparison and female age-subgroup differences were not significant
Derived from the full evaluation — not a separate score.
Strengths
The study applies both the disease-specific HAE-QoL and generic SF-12v2 instruments, permitting complementary characterization of disease burden.
↳ Methods, p.66
One hundred adults were recruited through nine specialist centers spanning Buenos Aires and four provinces, adding a rare-disease dataset from an underdescribed national setting.
↳ Methods, p.65; Results, p.66
The Discussion compares the observed burden with the Lumry cohort and places treatment availability within a Latin American context.
↳ Discussion, p.70; References 8 and 13
Limitations
The Abstract says differences by sex and every age group were demonstrated, but Results report no significant female age-subgroup differences and insufficient male samples for formal sex comparison.
↳ Abstract, p.64; Results, p.67
The paper describes the cohort as highly representative of all Argentine HAE patients despite specialist-center recruitment and acknowledged nonparticipation by patients treated in distant nonspecialist settings.
↳ Discussion, pp.69–70
No recruitment denominator or response rate is reported, the general-population SF-12v2 reference is unnamed, and the depression-screen method and threshold are not described.
↳ Methods, pp.65–66; Results and Figure 3, pp.67–69
The descriptive cross-sectional design and validated HAE-QoL and SF-12v2 instruments support the overall conclusion that quality of life was reduced in this specialist-treated cohort. Sampling transparency is limited by the absence of a recruitment denominator, response rate, and nonparticipant analysis, while Figure 3 does not identify the general-population reference used for comparison. The Abstract overstates subgroup findings relative to the qualified Results, and the depression-screen procedure is not described in Methods. The Discussion engages relevant literature but weakens its contextual credibility by calling the sample nationally representative despite acknowledging selection bias and excluded nonspecialist-managed patients.
Nabu’s assessment, alongside the field’s view.
Are you an author of this paper?
Limited2.9
Confidence mediumThe study adds a multicenter Argentine dataset to established international evidence that HAE is associated with reduced health-related quality of life. Its advance is geographic and descriptive rather than mechanistic or interventional.
“Los puntajes de este estudio coinciden con los de investigaciones previas.”
A cross-sectional design and two validated questionnaires fit the descriptive objective, but specialist-center volunteer recruitment lacks a denominator or response rate. The general-population SF-12v2 reference is also not identified or formally compared.
“Los pacientes fueron contactados por vía telefónica para participar en el estudio o, bien, durante la consulta programada.”
The objective, methods, questionnaire results, and conclusion follow a readable structure. Reporting is reduced because the Abstract says subgroup differences were demonstrated while Results report no significant female age differences and no formal sex comparison.
“Las muestras pequeñas de los subgrupos de hombres impidieron realizar la comparación estadística formal basada en el sexo.”
The Discussion compares findings with international and Latin American literature and explicitly mentions selection and information bias. It nevertheless labels the cohort highly representative of all Argentine patients despite acknowledging that distant nonspecialist-managed cases did not participate.
“puede considerarse altamente representativa de toda la población Argentina”
Caveats4 of 4 checks
Secondary subgroup and depression findings are not fully supported by the corresponding Results and Methods descriptions. The principal sample counts and overall quality-of-life findings remain internally consistent.
Ethics approval, written consent, anonymized central analysis, and pharmaceutical funding are declared. No unaddressed conduct concern in the supplied text meets a noted or concern threshold.
Flags: 2 declared / 5 total
8 of 10 checkable references verified
13 references in manuscript 2 are books, websites or datasets — counted, but not index-checkable 1 could not be checked — not the same as no match found
No retraction notice found in Retraction Watch.
Sources: Retraction Watch ✓
Where this paper’s evidence sits on the path from initial observation to real-world use.
The questionnaires characterize burden under routine specialist-care conditions, but the study does not evaluate a therapy, service model, or implementation strategy. Substantial additional work would therefore be required before practice change could be attributed to these findings.
AI-generated, human-governed. Something look off? Contact us to request a review.